Vantage Investment Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Vantage Investment Advisors’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$28K	Hold	375	–	–	0.01%	371
2018 Q2	$25K	Hold	375	–	–	0.01%	374
2018 Q1	$23K	Hold	375	–	–	0.01%	402
2017 Q4	$24K	Hold	375	–	–	0.01%	417
2017 Q3	$25K	Hold	375	–	–	0.01%	400
2017 Q2	$24K	Hold	375	–	–	0.01%	395
2017 Q1	$22K	Hold	375	–	–	0.01%	386
2016 Q4	$21K	Sell	375 -160	-30%	-$9.21K	0.01%	395
2016 Q3	$33K	Sell	535 -164	-23%	-$10.7K	0.01%	302
2016 Q2	$44K	Hold	699	–	–	0.02%	278
2016 Q1	$42K	Hold	699	–	–	0.02%	266
2015 Q4	$49K	Hold	699	–	–	0.02%	240
2015 Q3	$46K	Hold	699	–	–	0.03%	235
2015 Q2	$55K	Sell	699 -324	-32%	-$25.2K	0.03%	234
2015 Q1	$78K	Buy	1,023 +488	+91%	+$35.9K	0.02%	271
2014 Q4	$36K	Hold	535	–	–	0.02%	283
2014 Q3	$34K	Hold	535	–	–	0.02%	271
2014 Q2	$33K	Hold	535	–	–	0.02%	294
2014 Q1	$30K	Hold	535	–	–	0.02%	281
2013 Q4	$29K	Buy	+535	New	+$26.8K	0.02%	273

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MIH

Madison Investment Holdings Madison, Wisconsin $6.16B AUM 11.67% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BCM

Barometer Capital Management Toronto, Ontario, Canada $360M AUM 83.37% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Vantage Investment Advisors's PJP Position: Q3 2018 in Review

Vantage Investment Advisors held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2018 at 375 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #371.

Vantage Investment Advisors first reported a position in PJP in Q4 2013 and has held it in 20 quarters since. The position peaked at $78K in Q1 2015. 96 funds tracked by Wall St. Rank hold PJP as of Q3 2018.

Vantage Investment Advisors held 375 shares of Invesco Pharmaceuticals ETF worth $28K as of Q3 2018.
Vantage Investment Advisors left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2018.
Invesco Pharmaceuticals ETF made up 0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #371 holding.
Vantage Investment Advisors first reported a position in Invesco Pharmaceuticals ETF in Q4 2013 and has held it in 20 quarters since.
Vantage Investment Advisors's Invesco Pharmaceuticals ETF position peaked at $78K in Q1 2015.
96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.